Stock BIG1 BIO-GATE AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bio-Gate AG

Equities

BIG1

DE000BGAG981

Medical Equipment, Supplies & Distribution

Market Closed - Deutsche Boerse AG
Other stock markets
 11:20:01 2024-04-26 am EDT 		5-day change 1st Jan Change
0.98 EUR -2.00% Intraday chart for Bio-Gate AG -2.00% -7.55%
2023 Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 6.499 6.499 29.18 20.78 9.055 9.055 -
Enterprise Value (EV) 1 6.499 6.499 29.18 20.78 9.055 9.055 9.055
P/E ratio - - - - - - -
Yield - - - - - - -
Capitalization / Revenue 1.86 x 1.27 x 4.68 x 3.47 x 1.29 x 1.1 x 0.91 x
EV / Revenue 1.86 x 1.27 x 4.68 x 3.47 x 1.29 x 1.1 x 0.91 x
EV / EBITDA - -12.4 x -84.6 x -13.4 x -12.1 x -1,811 x 8.27 x
EV / FCF - - -32.2 x - -8.54 x -16.8 x 121 x
FCF Yield - - -3.11% - -11.7% -5.96% 0.83%
Price to Book - - - - - - -
Nbr of stocks (in thousands) 4,304 4,304 7,639 7,639 9,240 9,240 -
Reference price 2 1.510 1.510 3.820 2.720 0.9800 0.9800 0.9800
Announcement Date 6/8/20 4/26/21 4/7/22 4/29/23 - - -
1EUR in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 3.487 5.132 6.235 5.99 7 8.21 10
EBITDA 1 - -0.522 -0.345 -1.547 -0.75 -0.005 1.095
EBIT 1 - -0.819 -0.538 -1.787 -1.025 -0.235 0.815
Operating Margin - -15.96% -8.63% -29.83% -14.64% -2.86% 8.15%
Earnings before Tax (EBT) - - - - - - -
Net income -1.031 - - - - - -
Net margin -29.57% - - - - - -
EPS - - - - - - -
Free Cash Flow 1 - - -0.907 - -1.06 -0.54 0.075
FCF margin - - -14.55% - -15.14% -6.58% 0.75%
FCF Conversion (EBITDA) - - - - - - 6.85%
FCF Conversion (Net income) - - - - - - -
Dividend per Share - - - - - - -
Announcement Date 6/8/20 4/26/21 4/7/22 4/29/23 - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt - - - - - - -
Net Cash position - - - - - - -
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - -0.91 - -1.06 -0.54 0.08
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets - - - - - - -
Book Value Per Share - - - - - - -
Cash Flow per Share - - - - - - -
Capex 1 - - 0.27 - 0.1 0.2 0.5
Capex / Sales - - 4.38% - 1.43% 2.44% 5%
Announcement Date 6/8/20 4/26/21 4/7/22 4/29/23 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
BIO-GATE AG Stock Bio-Gate AG
-7.55% 9.67M
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. BIG1 Stock
  4. Financials Bio-Gate AG